Comparison results
Results: Differences Similar | ✘K71.6 | ✘K73 | ||||||||||
Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
Distinctive symptoms | ||||||||||||
Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
hepatitis b | — | 83% | ||||||||||
viral hepatitis c | — | 79% | ||||||||||
hepatitis c | — | 76% | ||||||||||
hepatitis | — | 75% | ||||||||||
cirrhosis of the liver | — | 73% | ||||||||||
liver failure | — | 73% | ||||||||||
not classified in other categories | — | 71% | ||||||||||
liver diseases | — | 69% | ||||||||||
autoimmune hepatitis | — | 68% | ||||||||||
consequences of alcohol abuse | — | 62% | ||||||||||
medicinal hepatitis | — | 61% | ||||||||||
chronic liver failure | — | 58% | ||||||||||
hepatic cell carcinoma | — | 57% | ||||||||||
alcohol is abusing | — | 54% | ||||||||||
is influenced | — | 54% | ||||||||||
viral hepatitis d | — | 49% | ||||||||||
yellow sclera | — | 46% | ||||||||||
gradual deterioration of | — | 46% | ||||||||||
benign neoplasms | — | 45% | ||||||||||
metabolic disorder | — | 44% | ||||||||||
acute viral hepatitis | — | 44% | ||||||||||
medicinal hepatotoxicity | — | 44% | ||||||||||
hypertension | — | 43% | ||||||||||
acute hepatitis | — | 42% | ||||||||||
cancer | — | 42% | ||||||||||
abdominal discomfort | — | 41% | ||||||||||
there are no complaints | — | 40% | ||||||||||
consequences of infection | — | 40% | ||||||||||
oncology | — | 39% | ||||||||||
increased fatigue | — | 39% | ||||||||||
arterial bleeding | — | 38% | ||||||||||
toxic liver | — | 38% | ||||||||||
consequences of taking medications | — | 38% | ||||||||||
delayed reaction | — | 37% | ||||||||||
positive | — | 37% | ||||||||||
jaundice | — | 36% | ||||||||||
bloating | — | 36% | ||||||||||
no appetite | — | 32% | ||||||||||
quickly gets tired | — | 31% | ||||||||||
there is emaciation in the neck | — | 31% | ||||||||||
subacute condition | — | 31% | ||||||||||
bleeding | — | 30% | ||||||||||
diseases of the gastrointestinal tract | — | 29% | ||||||||||
weakness | — | 28% |
Instructions
Video
|